Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RNA, U1 small nuclear 1 | 0.608 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
stabilin 2 | 0.743 | 0.423 | 9.2E-62 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
WRN RecQ like helicase | 0.524 | 0.808 | 2.6E-34 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | 0.644 | 0.615 | 2.8E-27 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
multimerin 1 | 0.465 | 0.846 | 2.1E-25 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
lipase maturation factor 1 | 0.769 | 0.231 | 5.1E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
zinc metallopeptidase STE24 | 0.517 | 0.731 | 8.9E-16 |
|
disease | 0.460 | None | 1.000 | 6 | 0 | 2003 | 2016 | ||||||||
|
phosphoenolpyruvate carboxykinase 1 | 0.608 | 0.538 | 8.7E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
angiopoietin like 3 | 0.584 | 0.577 | 1.6E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
lipin 1 | 0.601 | 0.692 | 6.5E-13 |
|
disease | 0.300 | None | 0.909 | 10 | 0 | 2001 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 S | 0.595 | 0.692 | 6.3E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
follicle stimulating hormone receptor | 0.539 | 0.654 | 1.4E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
angiopoietin like 4 | 0.498 | 0.731 | 2.3E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
perilipin 1 | 0.590 | 0.654 | 3.1E-11 |
|
disease | 0.140 | None | 0.750 | 4 | 0 | 2011 | 2019 | ||||||||
|
nucleobindin 2 | 0.540 | 0.731 | 2.0E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
BSCL2 lipid droplet biogenesis associated, seipin | 0.545 | 0.692 | 1.1E-09 |
|
disease | 0.700 | None | 1.000 | 15 | 1 | 2002 | 2019 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2003 | 2019 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2008 | 2008 | ||||||||
|
progestagen associated endometrial protein | 0.430 | 0.846 | 3.1E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 |